Transitional cell carcinoma epidemiology and demographics: Difference between revisions
No edit summary |
|||
| Line 11: | Line 11: | ||
===Age=== | ===Age=== | ||
Transitional cell carcinoma is typically a tumor of older patients, with the average age of presentation being 65, and the majority of patients being over the age of 60. | *Transitional cell carcinoma is typically a tumor of older patients, with the average age of presentation being 65, and the majority of patients being over the age of 60. | ||
*Transitional cell carcinoma of the urinary bladder is rare in young adults, as less than 1% of such tumors present in the first 4 decades of life.<ref name="NomikosPappas2011">{{cite journal|last1=Nomikos|first1=Michael|last2=Pappas|first2=Athanasios|last3=Kopaka|first3=Maria-Emmanouela|last4=Tzoulakis|first4=Stavros|last5=Volonakis|first5=Ioannis|last6=Stavrakakis|first6=Georgios|last7=Avgenakis|first7=Georgios|last8=Anezinis|first8=Ploutarchos|title=Urothelial Carcinoma of the Urinary Bladder in Young Adults: Presentation, Clinical behavior and Outcome|journal=Advances in Urology|volume=2011|year=2011|pages=1–4|issn=1687-6369|doi=10.1155/2011/480738}}</ref> | |||
===Gender=== | ===Gender=== | ||
There is a strong male predilection (M:F = 4:1), at least in part due to many tumors (especially historically) having been due to industrial exposure. | There is a strong male predilection (M:F = 4:1), at least in part due to many tumors (especially historically) having been due to industrial exposure. | ||
Revision as of 14:29, 15 February 2016
|
Transitional cell carcinoma Microchapters |
|
Differentiating Transitional cell carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Transitional cell carcinoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Transitional cell carcinoma epidemiology and demographics |
|
FDA on Transitional cell carcinoma epidemiology and demographics |
|
CDC on Transitional cell carcinoma epidemiology and demographics |
|
Transitional cell carcinoma epidemiology and demographics in the news |
|
Blogs on Transitional cell carcinoma epidemiology and demographics |
|
Directions to Hospitals Treating Transitional cell carcinoma |
|
Risk calculators and risk factors for Transitional cell carcinoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology and Demographics
- Transitional cell carcinoma of the renal pelvis, accounts for only 7% of all kidney tumors.[1]
- Transitional cell cancer of the ureter, accounts for only 1 of every 25 upper tract tumors.
- They are curable in more than 90% of patients if they are superficial and confined to the renal pelvis or ureter.
- Patients with deeply invasive tumors that are still confined to the renal pelvis or ureter have a 10% to 15% likelihood of cure.
- Patients with tumors with penetration through the urothelial wall or with distant metastases usually cannot be cured with currently available forms of treatment.
Age
- Transitional cell carcinoma is typically a tumor of older patients, with the average age of presentation being 65, and the majority of patients being over the age of 60.
- Transitional cell carcinoma of the urinary bladder is rare in young adults, as less than 1% of such tumors present in the first 4 decades of life.[2]
Gender
There is a strong male predilection (M:F = 4:1), at least in part due to many tumors (especially historically) having been due to industrial exposure.
References
- ↑ Transitional cell cancer. National cancer institute. http://www.cancer.gov/types/kidney/hp/transitional-cell-treatment-pdq#section/_1
- ↑ Nomikos, Michael; Pappas, Athanasios; Kopaka, Maria-Emmanouela; Tzoulakis, Stavros; Volonakis, Ioannis; Stavrakakis, Georgios; Avgenakis, Georgios; Anezinis, Ploutarchos (2011). "Urothelial Carcinoma of the Urinary Bladder in Young Adults: Presentation, Clinical behavior and Outcome". Advances in Urology. 2011: 1–4. doi:10.1155/2011/480738. ISSN 1687-6369.